Innovation Direct™ to be at Forefront of Marketing Campaign for Miller Biopsy Needle Invention

Miami, FL, November 30, 2011 --(PR.com)-- An innovative new product that offers potential life saving benefits, the Miller Biopsy Needle, has been developed by Alvin L. Miller of Cape Coral, Florida. The invention's unique design and features render it an effective deterrent against the possibility of contaminated cells being left behind in healthy tissue as the biopsy needle is withdrawn.

Cancer screenings are vital procedures that often prove to be life saving. However, an inherent danger in conventional biopsy-related screenings is that needles can inadvertently contaminate otherwise healthy tissue. This can result in the rapid spread of cancerous cells throughout the body, resulting in catastrophic consequences. Additionally, these tests can often be very expensive, making them unaffordable to individuals with inadequate or no insurance coverage.

The Miller Biopsy Needle will serve to eliminate the risk of contamination during the testing process by effectively sterilizing the fluid at the top of the needle. The product will feature needles in a wide variety of lengths, much like conventional biopsy needles. The Miller Biopsy Needle will also make consistent and frequent monitoring of a potentially malignant tumor a simpler, safer, and more efficient proposition, thereby helping to increase the chances of effective treatment and survival.

The ease of use offered by the Miller Biopsy Needle will play a major role in reducing the need for expensive, invasive and potentially dangerous surgeries by allowing for the detection and treatment of cancerous tumors in a timely manner. The product could also conceivably lend itself to serve as a conduit for the direct insertion of medication into the patient’s affected area, thereby serving as a valuable preventive tool in the field of oncology.

The inventor of the Miller Biopsy Needle now seeks a third party licensee to manufacture, market, and distribute the product for him under a royalty agreement. Potential licensees in the medical products industry are currently being targeted as candidates to eventually commercialize the Miller Biopsy Needle on a worldwide basis.

In August 2011, Mr. Miller contracted Miami, Florida-based product management services leader Innovation Direct™ to represent the Miller Biopsy Needle to potential licensees for a 2 year period. Innovation Direct™ obtains the maximum amount of exposure for the products that it represents through participation in multiple and diverse industry-leading trade shows each year. Exhibits that Innovation Direct™ has attended in recent years include the SHOT Show, the International Home and Housewares Show, the World of Concrete Show, the National Hardware Show, Licensing International, the SEMA and AAPEX Shows and the ERA D2C Convention.

Potential licensees interested in obtaining more information about the Miller Biopsy Needle and discussing licensing opportunities with respect to the product can contact the Manufacturer Response Department of Innovation Direct™ at (877) 991-0909 ext. 4285 or at MR@innovationdirectonline.com.

###